Sirtex gets nod for resin microsphere use in Brazil for HCC treatment

By AuntMinnie.com staff writers

September 16, 2022 -- Radiation oncology firm Sirtex Medical said that the Brazilian National Agency of Supplementary Health (ANS) has approved the use of its SIR-Spheres Y-90 resin microspheres for treatment of intermediate and advanced stage hepatocellular carcinoma (HCC).

ANS updated its List of Health Procedures and Events to recommend SIR-Spheres for use in selective internal radiation therapy, according to Sirtex. The Brazilian Health Regulatory Agency (ANVISA) initially approved SIR-Spheres for SIR-Spheres in 2014.


Copyright © 2022 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
What's this?
Sign in using your social networking
account:
(What's this?)


Forgot your password?
|
View our privacy policy.